Crossref
The Importance of the DEIC/GEMIC/SBC 2021 Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis to Clinical Practice
ABC: Heart Failure & Cardiomyopathy · 2021
DOI: 10.36660/abchf.20210021 ↗Kurz gefasst
Fachartikel in der Zeitschrift ABC: Heart Failure & Cardiomyopathy, 2021. Verfasst von Marcus Vinicius Simões und 1 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Simões, M. V., & Fernandes, F. (2021). The Importance of the DEIC/GEMIC/SBC 2021 Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis to Clinical Practice. ABC: Heart Failure & Cardiomyopathy. https://doi.org/10.36660/abchf.20210021
Vancouver
Simões MV, Fernandes F. The Importance of the DEIC/GEMIC/SBC 2021 Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis to Clinical Practice. ABC: Heart Failure & Cardiomyopathy. 2021. doi:10.36660/abchf.20210021
BibTeX
@article{Simes2021,
author = {Simões, Marcus Vinicius and Fernandes, Fabio},
title = {The Importance of the DEIC/GEMIC/SBC 2021 Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis to Clinical Practice},
journal = {ABC: Heart Failure & Cardiomyopathy},
year = {2021},
doi = {10.36660/abchf.20210021}
}
EUVIMED